Andy Moore, CEO of B. Riley Securities, commented: "The deep industry expertise and proven execution capabilities of this team significantly enhances our accomplished healthcare and life sciences capital markets franchise. Coupled with the recent addition of FocalPoint, B. Riley has firmly established its position as a leading advisor to organizations and investors across the healthcare dealmaking continuum."